Novadiscovery Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 39
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $3.03M
Latest Deal Amount
  • Investors
  • 5

Novadiscovery General Information

Description

Developer of a silico clinical trial simulation platform designed to optimize drug R&D and strengthen healthcare decision-making. The company's platform builds a community of virtual patients as on-demand digital lab rats, allows the prediction of the effectiveness of a therapy or the diagnostic value of a biomarker at the individual and the population level, and compares them with those of competitors, thereby enabling healthcare providers to unlock the potential of modeling and simulation to de-risk the R&D of new therapies for the benefit of patients, predicts drug efficacy, and creates the target combinations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Primary Office
  • 1 Place Verrazzano
  • 69009 Lyon
  • France
+33 09 00 00 00 00

Novadiscovery Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novadiscovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A2) 16-Feb-2021 $3.03M 00.00 000.00 Completed Generating Revenue
6. Grant 19-Jan-2021 00.000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 09-Jan-2020 00.000 00.000 000.00 Completed Generating Revenue
4. Accelerator/Incubator 09-Feb-2016 00000 Completed Generating Revenue
3. Grant 13-Jun-2015 00000 Completed Generating Revenue
2. Early Stage VC 18-Aug-2014 $469K $656K 00.000 Completed Startup
1. Early Stage VC 18-Jun-2010 $186K $186K 00000 Completed Startup
To view Novadiscovery’s complete valuation and funding history, request access »

Novadiscovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 000.00 000.00 00 000.00 0.000
A Shares 00,000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000 0000.00 0000.00 00 0000.00 0.00
BSA 2015-1 0,000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 000.00 000.00 00 000.00 0.000
ABSA 2014-1 8,358 $50.67 $50.67 1x $50.67 5.32%
Ordinary 14,813 $12.44 $12.44 1x $12.44 9.42%
To view Novadiscovery’s complete cap table history, request access »

Novadiscovery Executive Team (6)

Name Title Board Seat Contact Info
François-Henri Boissel Co-Founder, Chief Executive Officer & President
Pascale Boissel Chief Financial Officer
Grégoire Boutonnet Chief Operating Officer
Frederic Cogny Co-Founder & Chief Technology Officer
Jean-Pierre Boissel Co-Founder, Chief Scientific Officer & Chairman of the Scientific Advisory Board
You’re viewing 5 of 6 executive team members. Get the full list »

Novadiscovery Board Members (6)

Name Representing Role Since
Cédric Mauvernay Debiopharm Innovation Fund Board Member 000 0000
Isabelle Vitali Sanofi Board Member 000 0000
Jean-Pierre Boissel Novadiscovery Co-Founder, Chief Scientific Officer & Chairman of the Scientific Advisory Board 000 0000
Philippe Chambon Ph.D Self Board Member 000 0000
Tanja Dowe Debiopharm Innovation Fund Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Novadiscovery Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novadiscovery Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sanofi Corporation Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund 000 0000 000000 0
Debiopharm Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
BigBooster Accelerator/Incubator 000 0000 000000 0
H2020 Corporation 000 0000 000000 0
To view Novadiscovery’s complete investors history, request access »